Does systematic 2-field lymphadenectomy for esophageal malignancy offer a survival advantage? Results from 178 consecutive patients

Diseases of the Esophagus

Volumn 21, Issue 7, 2008, Pages 612-618

  Martin, D J ^a   Church, N G ^a   Kennedy, C W ^a   Falk, Gregory L ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NONE   (Australia)

Author keywords

Esophageal cancer; Esophagectomy; Lymphadenectomy; Survival

Indexed keywords

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENT DISEASE; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT DURATION;

ABDOMEN; AGED; CARCINOMA; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; THORAX; TREATMENT OUTCOME;

EID: 53149110820     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2008.00826.x     Document Type: Article

References (36)

1. Jamieson G G, Mathew G, Ludemann R, Wayman J, Myers J C, Devitt P G. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004; 91: 943-7.
2. Lerut T, Nafteux P, Moons J et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: Impact on staging, disease-free surviAal, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 2004; 240: 962-72.
3. Dexter S P, Sue-Ling H, McMahon M J, Quirke P, Mapstone N, Martin I G. Circumferential resection margin involvement: An independent predictor of survival following surgery for oesophageal cancer. Gut 2001; 48: 667-70.
4. Altorki N K. The rationale for radical resection. Surg Oncol Clin N Am 1999; 8: 295-305.
5. Hagen J A, DeMeester S R, Peters J H, Chandrasoma P, DeMeester T R Curative resection for esophageal adenocarcinoma: Analysis of 100 en bloc esophagectomies. Ann Surg 2001; 234: 520-30.
6. Hulscher J B, van Sandick J W, de Boer A G et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347: 1662-9.
7. Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma Ann Surg 2001; 234: 581-7.
8. Greene F L, Page D L, Fleming I D. etal., (eds). AJCC Cancer Staging Manual, 6th edn. New York, NY: Springer, 2002; 127-37.
9. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma -2nd English edn. Gastric Cancer 1998; 1: 10-24.
10. Orringer M B, Marshall B, Iannettoni M D. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 1999; 230: 392-403.
11. Putnam J B, Suell D M, McMurtrey M J et al. Comparison of three techniques of esophagectomy within a residency training program. Ann Thorac Surg 1994; 57: 319-25.
12. Lieberman M D, Shriver C D, Bleckner S et al. Carcinoma of the esophagus. Prognostic significance of histologic type. J Thorac Cardiovasc Surg 1995; 109: 130-8.
13. Gertsch P, Vauthey J N, Lustenberger A A et al. Long-term results of transhiatal esophagectomy for esophageal carcinoma. A multivariate analysis of prognostic factors. Cancer 1993; 72: 2312-9.
14. Karl R C, Schreiber R, Boulware D et al. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor-Lewis esophagogastrectomy. Ann Surg 2000; 231: 635-43.
15. Vigneswaran W T, Trastek V F, Pairolero P C, Deschamps C, Daly R C, Allen M S. Transhiatal esophagectomy for carcinoma of the esophagus. Ann Thorac Surg 1993; 56: 838-44.
16. Zhang X, Watson D I, Jamieson G G, Lally C, Bessell J R, Devitt P G. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction. Anz J Surg 2005; 75: 513-9.
17. Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991; 48: 411-29.
18. Noguchi T, Wada S, Takeno S, Hashimoto T, Moriyama H, Uchida Y. Two-step three-field lymph node dissection is beneficial for thoracic esophageal carcinoma. Dis Esophagus 2004; 17: 27-31.
19. Tabira Y, Okuma T, Kondo K, Kitamura N J. Indications for three-field dissection followed by esophagectomy for advanced carcinoma of the thoracic esophagus. Thorac Cardiovasc Surg 1999; 117: 239-45.
20. Fujita H, Kakegawa T, Yamana H et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 1995; 222: 654-62.
21. Baba M, Aikou T, Natsugoe S et al. Quality of life following esophagectomy with three-field lymphadenectomy for carcinoma, focusing on its relationship to vocal cord palsy. Dis Esophagus 1998; 11: 28-34.
22. Goldminc M, Maddern G, Le Prise E, Meunier B, Campion J P, Launois B. Oesophagectomy by a transhiatal approach or thoracotomy: A prospective randomized trial. Br J Surg 1993; 80: 367-70.
23. Chu K M, Law S Y, Fok M, Wong J. A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma. Am J Surg 1997; 174: 320-4.
24. Jacobi C A, Zieren H U, Muller J M, Pichlamaier H. Systematic lymphadenectomy in esophageal carcinoma -preliminary results of a prospective randomized study Zentralbl Chir 1996; 121: 110-5.
25. Herbella F A, Del Grande J C, Colleoni R. Efficacy of mediastinal lymphadenectomy in transhiatal esophagectomy with and without diaphragm opening: A cadaveric study. Dis Esophagus 2002; 15: 160-2.
26. Feith M, Stein H J, Siewert J R. Pattern of lymphatic spread of Barrett's cancer. World J Surg 2003; 27: 1052-7.
27. Waterman T A, Hagen J A, Peters J H, DeMeester S R, Taylor C R, Demeester T R. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. Ann Thorac Surg 2004; 78: 1161-9.
28. Bonavina L, Ferrero S, Midolo V, Buffa R, Cesana B, Peracchia A J. Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction. Gastrointest Surg 1999; 3: 468-76.
29. McCulloch P, Nita M E, Kazi H, Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. [Systematic Review]Cochrane Database Syst Rev 2004; 3 AN: 00075320-100000000
30. Degiuli M, Sasako M, Calgaro M et al. (Italian Gastric Cancer Study Group). Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 2004; 30: 303-8.
31. Bonenkamp J J, Hermans J, Sasako M, van de Velde C J. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 1999; 340: 908-14.
32. Cuschieri A, Weeden S, Fielding J et al. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999; 79: 1522-30.
33. Martin D J, Bessell J R, Chew A, Watson D I. Thoracoscopic and laparoscopic esophagectomy: Initial experience and outcomes. Surg Endosc 2005; 19: 1597-601.
34. Smithers B M, Gotley D C, Martin I, Thomas J M. Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg 2007; 245: 232-40.
35. Huscher C G, Mingoli A, Sgarzini G et al. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: Five-year results of a randomized prospective trial. Ann Surg 2005; 241: 232-7.
36. Noshiro H, Nagai E, Shimizu S, Uchiyama A, Tanaka M. Laparoscopically assisted distal gastrectomy with standard radical lymph node dissection for gastric cancer. Surg Endosc 2005; 19: 1592-6.